Aclaris Therapeutics Inc (NASDAQ:ACRS)
| 14.43 Delayed Data As of Jun 24 |  -1.42 / -8.96%Today’s Change | 9.26 Today|||52-Week Range 19.97 | -0.76% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Walker Neal S President & Chief Executive Officer |  Sale | 3/11/2022 | 56,303 | $15.91 | $895.8K | -8.79% |
Monahan Joseph B Chief Scientific Officer | Sale | 4/18/2022 | 30,000 | $16.28 | $488.4K | -10.43% |
Monahan Joseph B Chief Scientific Officer | Sale | 3/10/2022 | 27,165 | $15.71 | $426.8K | -9.87% |
Walker Neal S President & Chief Executive Officer | Sale | 4/21/2022 | 25,000 | $15.24 | $381.0K | -4.19% |
Walker Neal S President & Chief Executive Officer | Sale | 4/22/2022 | 25,000 | $15.04 | $376.0K | -4.50% |
Walker Neal S President & Chief Executive Officer | Sale | 4/25/2022 | 20,000 | $15.18 | $303.6K | -5.63% |
Aisling Capital Management Lp Director | Sale | 6/17/2022 | 19,565 | $15.14 | $296.2K | -7.62% |
Ruffo Frank Chief Financial Officer | Sale | 3/10/2022 | 12,823 | $15.55 | $199.4K | -9.87% |
Walker Neal S President & Chief Executive Officer | Sale | 2/09/2022 | 3,595 | $12.66 | $45.5K | +13.19% |
Gordon David /aclaris/ Chief Medical Officer | Sale | 7/13/2021 | 2,631 | $16.98 | $44.7K | -14.42% |
Page of 3